Statement: There were no cases of Oesophageal spasming, Diastolic dysfunction or thrombosis observed in the primary trial.
Primary_evidence: Adverse Events 1:   Total: 0/244 (0.00%)   Pregnancy *0/244 (0.00%)   Endocervical cancer *0/244 (0.00%)   Nosocomial pneumonia *0/244 (0.00%)   Venous thrombosis *0/244 (0.00%) Adverse Events 2:   Total: 5/255 (1.96%)   Pregnancy *1/255 (0.39%)   Endocervical cancer *1/255 (0.39%)   Nosocomial pneumonia *2/255 (0.78%)   Venous thrombosis *1/255 (0.39%)